In the News
powered by Ovast-
Glaxo Undeterred By Human Genome 'Poison Pill' - Boston.com
google.com 1 week, 5 days agoNew York Times Glaxo undeterred by Human Genome 'poison pill' Boston.com LONDON,GlaxoSmithKline says it will persist with its bid to take over US company Human Genome Sciences despite the target's new `poison pill' defense. In a statement issued after the market closed on Thursday, GSK said it believes its $13 per share ... GlaxoSmithKline target adopts 'poison pill' Human Genome in Talks With Potential Suitors GlaxoSmithKline PLC GSK statement on tender offer to acquire HGS
-
GlaxoSmithKline To Take Human Genome Sciences Buyout Offer To Shareholders
washingtonpost.com 2 weeks, 6 days agoBritish drugmaker GlaxoSmithKline said Wednesday it will no longer wait for Human Genome Sciences to consider an acquisition offer and will instead appeal directly to the Rockville firm’s shareholders to accept its $13-per-share asking price. Read full article >>









Loading More Stories